Neurological Manifestations of Varicella Zoster
- Author: Wayne E Anderson, DO; Chief Editor: Karen L Roos, MD more...
Background
Herpes zoster presents in many ways. It should not be considered simply a self-limited dermatomal rash with pain. Varicella-zoster virus (VZV) infection is an acute neurologic disease that warrants immediate evaluation. A common misperception is that VZV always is a benign disorder.
Following initial infection, usually as chickenpox in childhood, VZV remains dormant in the dorsal spinal root ganglion neurons and the fifth cranial nerve ganglion neurons. Upon reactivation, a spectrum of signs and symptoms can occur, including a self-limited painful rash, pain without skin manifestations, keratitis, vertigo, and spinal cord disease with weakness. Once VZV infection resolves, many individuals continue to suffer pain, a condition known as postherpetic neuralgia (PHN).
Herpes zoster in the ophthalmic (V1) distribution of the trigeminal nerve. Note the unilateral distribution of the rash and how the V1 distribution may extend to the tip of the nose. Though at risk for keratitis with zoster in this distribution, the patient had a normal ocular examination. Patient consented to picture distribution for educational use; written permission on file; contributed by JS Huff. Pathophysiology
VZV remains latent in the dorsal root ganglia after an initial infection (chickenpox). Host immunologic mechanisms suppress replication of the virus, but VZV reactivates when the host mechanisms fail to contain the virus. This occurs from a wide spectrum of issues, from stress to severe immunosuppression. Occasionally this follows direct trauma. VZV viremia occurs frequently with chickenpox but also may occur with herpes zoster, albeit with a lower viral load. The virus migrates from the sensory root and produces a dermatomal sensory loss and a characteristic painful rash.
Inflammatory involvement may include the leptomeninges. When the cervical and lumbar roots are involved, motor involvement (which often is overlooked) may be seen, depending on the virulence and/or extent of migration.
VZV is a DNA virus. The viral genome encodes approximately 70 proteins. Once activated at the spinal root or cranial nerve neurons, an inflammatory response occurs that also encompasses the leptomeninges. Both plasma cells and lymphocytes are noted. In at least one case of motor neuron involvement, lymphocytic infiltration and myelin breakdown were observed with preservation of axons.
Epidemiology
Frequency
United States
Incidence is approximately 5 per 1000 per year. Immunosuppression increases risk. The incidence of PHN increases with age. Half of patients older than 60 years may have a temporary or prolonged pain syndrome. Although 50% or more of patients with PHN may have resolution of the pain within 1-2 years, the remainder may have a continuing pain syndrome. Fortunately newer treatments are available for PHN.
Although the frequency of varicella zoster may decrease as the vaccinated children grow to adulthood, the present frequency of varicella zoster in adults may be increasing.
International
The international frequency is the same as for the United States.
Mortality/Morbidity
Ninety-five percent of patients with zoster experience severe pain. The acute pain and insomnia are most bothersome.
- Variant presentations of zoster (eg, keratitis, myelitis) may carry additional morbidity.
- Duration of symptoms, incidence of complications and duration of post-herpetic neuralgia if it should occur, are longer in immunocompromised patients.
- Complications may occur. For example, staphylococcal and streptococcal bacteria may superinfect the skin lesions and require treatment.
Race
Although the pathophysiology is uncertain, the vesicular eruption may be less frequent in African Americans. The reason is not clear.
Sex
- Prevalence in males and females is equal.
- Ertunc and colleagues suggested both that zoster frequency is higher in right-handed patients and that the rash appears more frequently on the left side in females.[1] The pathophysiology for these differences is uncertain.
Age
Although zoster can occur at any age after primary infection, incidence increases with age. Also troublesome is the increasing incidence of PHN with advancing age.
Ertunc V, Dane S, Karakuzu A, Deniz O. Higher herpes zoster infection frequency in right-handed patients and more frequent appearance in the left body side of females. Acta Derm Venereol. May 1997;77(3):245. [Medline].
Goh CL, Khoo L. A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic. Int J Dermatol. Sep 1997;36(9):667-72. [Medline].
Devinsky O, Cho ES, Petito CK, Price RW. Herpes zoster myelitis. Brain. Jun 1991;114 ( Pt 3):1181-96. [Medline].
Westenend PJ, Hoppenbrouwers WJ. [Fatal varicella-zoster encephalitis; a rare complication of herpes zoster]. Ned Tijdschr Geneeskd. Mar 21 1998;142(12):654-7. [Medline].
Svozilkova P, Rihova E, Diblik P, et al. Varicella zoster virus acute retinal necrosis following eye contusion: case report. Virol J. Aug 31 2005;2:77. [Medline].
Furuta Y, Fukuda S, Suzuki S, et al. Detection of varicella-zoster virus DNA in patients with acute peripheral facial palsy by the polymerase chain reaction, and its use for early diagnosis of zoster sine herpete. J Med Virol. Jul 1997;52(3):316-9. [Medline].
Fabian VA, Wood B, Crowley P, Kakulas BA. Herpes zoster brachial plexus neuritis. Clin Neuropathol. Mar-Apr 1997;16(2):61-4. [Medline].
Cresswell F, Eadie J, Longley N, Macallan D. Severe Guillain-Barré syndrome following primary infection with varicella zoster virus in an adult. Int J Infect Dis. Jun 5 2009;[Medline].
Stein GE. Pharmacology of new antiherpes agents: famciclovir and valacyclovir. J Am Pharm Assoc (Wash). Mar-Apr 1997;NS37(2):157-63. [Medline].
Kubeyinje EP. Cost-benefit of oral acyclovir in the treatment of herpes zoster. Int J Dermatol. Jun 1997;36(6):457-9. [Medline].
Schmader K, Levin M, Gnann J, McNeil S, Vesikari T, et al. Efficacy, immunogenicity, safety, and tolerability of zoster vaccine (ZV) in subjects 50 to 59 years of age (Poster/Abstract). Infectious Diseases Society of America. The 48th Annual Meeting of the Infectious Diseases Society of America. 10-21-2010;Vancouver, British Columbia, Canada:Ref Type: Abstract: 3363.
Morgan R, King D. Characteristics of patients with shingles admitted to a district general hospital. Postgrad Med J. Feb 1998;74(868):101-3. [Medline].
Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, et al. The Incidence and Clinical Characteristics of Herpes Zoster Among Children and Adolescents After Implementation of Varicella Vaccination. Pediatr Infect Dis J. Jun 16 2009;[Medline].
Galil K, Choo PW, Donahue JG, Platt R. The sequelae of herpes zoster. Arch Intern Med. Jun 9 1997;157(11):1209-13. [Medline].
Hong JJ, Elgart ML. Gastrointestinal complications of dermatomal herpes zoster successfully treated with famciclovir and lactulose. J Am Acad Dermatol. Feb 1998;38(2 Pt 1):279-80. [Medline].
Shapiro JS. Does varicella-zoster virus infection of the peripheral ganglia cause Chronic Fatigue Syndrome?. Med Hypotheses. Jun 9 2009;[Medline].
Rowbotham MC, Fields HL. The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia. Brain. Apr 1996;119 (Pt 2):347-54. [Medline].
Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain. Apr 1996;65(1):39-44. [Medline].
Oaklander AL, Romans K, Horasek S, et al. Unilateral postherpetic neuralgia is associated with bilateral sensory neuron damage. Ann Neurol. Nov 1998;44(5):789-95. [Medline].
Gilden DH, Cohrs RJ, Mahalingam R. VZV vasculopathy and postherpetic neuralgia: progress and perspective on antiviral therapy. Neurology. Jan 11 2005;64(1):21-5. [Medline].
Baik JS, Kim WC, Heo JH, Zheng HY. Recurrent herpes zoster myelitis. J Korean Med Sci. Aug 1997;12(4):360-3. [Medline].
Carreau JP, Gola R, Cheynet F, Guyot L. [Zona of the cranial nerves. Current aspects]. Rev Stomatol Chir Maxillofac. Oct 1998;99(3):155-64. [Medline].
Cohen JI. Varicella-zoster virus. The virus. Infect Dis Clin North Am. Sep 1996;10(3):457-68. [Medline].
Cohen JI, Brunell PA, Straus SE, Krause PR. Recent advances in varicella-zoster virus infection. Ann Intern Med. Jun 1 1999;130(11):922-32. [Medline].
Feder HM, LaRussa P, Steinberg S, Gershon AA. Clinical varicella following varicella vaccination: don't be fooled. Pediatrics. Jun 1997;99(6):897-9. [Medline].
Goldman GS. Universal varicella vaccination: efficacy trends and effect on herpes zoster. Int J Toxicol. Jul-Aug 2005;24(4):205-13. [Medline].
Liang MG, Heidelberg KA, Jacobson RM, McEvoy MT. Herpes zoster after varicella immunization. J Am Acad Dermatol. May 1998;38(5 Pt 1):761-3. [Medline].
Mainka C, Fuss B, Geiger H, et al. Characterization of viremia at different stages of varicella-zoster virus infection. J Med Virol. Sep 1998;56(1):91-8. [Medline].
Makeham TP, Croxson GR, Coulson S. Infective causes of facial nerve paralysis. Otol Neurotol. Jan 2007;28(1):100-3. [Medline].
Sawyer AR, Williams G. Misdiagnosis of burns: herpes zoster ophthalmicus. J Burn Care Res. Nov-Dec 2006;27(6):914-6. [Medline].
Sjaastad O, Bakketeig LS. The rare, unilateral headaches. Vaga study of headache epidemiology. J Headache Pain. Feb 2007;8(1):19-27. [Medline].
Sparks L, Russell C. The new varicella vaccine: efficacy, safety, and administration. J Pediatr Nurs. Apr 1998;13(2):85-94. [Medline].
Spiegel R, Miron D, Lumelsky D, Horovitz Y. Severe Meningoencephalitis Due to Late Reactivation of Varicella-Zoster Virus in an Immunocompetent Child. J Child Neurol. Jun 3 2009;[Medline].
Vu AQ, Radonich MA, Heald PW. Herpes zoster in seven disparate dermatomes (zoster multiplex): report of a case and review of the literature. J Am Acad Dermatol. May 1999;40(5 Pt 2):868-9. [Medline].
Wlodaver CG, Privett T, Livengood G. The merits of varicella vaccination for varicella non-immune health care workers. J Okla State Med Assoc. Dec 1996;89(12):430-2. [Medline].
Yi JY, Kim TY, Shim JH, et al. Histopathological findings, viral DNA distribution and lymphocytic immunophenotypes in vesicular and papular types of herpes zoster. Acta Derm Venereol. May 1997;77(3):194-7. [Medline].

